Asarina Pharma AB is a Swedish biotech company, which engages in the development of Sepranolone for allopregnanolonerelated stress, menstrual, and neurological disorders. The company was founded by Carl Torbjörn Bäckström and Mingde Wang in 2006 and is headquartered in Solna, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company